PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update PharmAla provides corporate update following AGM

PharmAla named an Intellectual Property Ontario Client PharmAla recieves a non-dilutive grant from IP Ontario (IPON) to support its patent work in international markets.

PharmAla granted a Controlled Drugs & Substances Dealer’s License by Health Canada PharmAla granted a Health Canada Controlled Drugs and Substances Dealer's License